Abstract

Heterologous <scp>SARS‐CoV</scp>‐2 vaccinations in patients with B‐cell lymphoid malignancies

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Immunogenicity of a heterologous COVID-19 vaccine after failed vaccination in a lymphoma patient.
Ajay K Gopal ... Alexander L Greninger
Cancer cell | VOL. 39
Ajay K Gopal, et. al.Ajay K Gopal ... Alexander L Greninger
26 Jun 2021
Efficacy and Safety of Ublituximab in Combination with Umbralisib (U2) in Patients with Chronic Lymphocytic Leukemia (CLL) By Treatment Status: A Sub-Analysis of the Phase 3 Unity-CLL Study
John M Pagel ... Jennifer L Cultrera
Blood | VOL. 138
John M Pagel, et. al.John M Pagel ... Jennifer L Cultrera
05 Nov 2021
Addressing a New Challenge in Chronic Lymphocytic Leukemia: Outcomes of Therapies after Exposure to Both a Covalent Bruton's Tyrosine Kinase Inhibitor and Venetoclax
Mazyar Shadman ...
Blood | VOL. 138
Mazyar Shadman, et. al.Mazyar Shadman ...
05 Nov 2021
Oral Ixazomib in Untreated Follicular Lymphoma Permits COVID-19 Vaccine Response and Its Efficacy Is Associated with Clinical Factors and Gene Expression Signatures
Ryan C Lynch ... Andrew J Cowan
Blood | VOL. 138
Ryan C Lynch, et. al.Ryan C Lynch ... Andrew J Cowan
05 Nov 2021
View more papers

More From: American Journal of Hematology

Paper Title
Journal
Date
Author
A randomized double-blind pilot study to evaluate the efficacy, safety, and tolerability of intravenous iron versus oral iron for the treatment of restless legs syndrome in patients with iron deficiency anemia.
Richard Allen ... Huzefa Bahrain
American journal of hematology | VOL. 99
Richard Allen, et. al.Richard Allen ... Huzefa Bahrain
01 Jun 2024
-
-
American Journal of Hematology | VOL. 99
--
01 Jun 2024
Toxicities associated with tyrosine kinase inhibitor maintenance following allogeneic hematopoietic cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Tamer Othman ... Matthew Mei
American journal of hematology | VOL. -
Tamer Othman, et. al.Tamer Othman ... Matthew Mei
28 May 2024
Outcomes following allogeneic hematopoietic cell transplantation relapse in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Tamer Othman ... Paul Koller
American journal of hematology | VOL. -
Tamer Othman, et. al.Tamer Othman ... Paul Koller
27 May 2024
View more papers